Results: 5

2.
Figure 2

Figure 2. From: A Randomized Controlled Trial of Structural Ecosystems Therapy for HIV Medication Adherence and Substance Abuse Relapse Prevention.

Estimated trajectories of substance use days, the proportion of medication adherence, and CD4-Cell count for women in SET and the Health Group.

Daniel J. Feaster, et al. Drug Alcohol Depend. ;111(3):227-234.
3.
Figure 5

Figure 5. From: A Randomized Controlled Trial of Structural Ecosystems Therapy for HIV Medication Adherence and Substance Abuse Relapse Prevention.

Moderation of estimated substance use days by initially living with a substance user for women in SET and the Health Group.

Daniel J. Feaster, et al. Drug Alcohol Depend. ;111(3):227-234.
4.
Figure 3

Figure 3. From: A Randomized Controlled Trial of Structural Ecosystems Therapy for HIV Medication Adherence and Substance Abuse Relapse Prevention.

Estimated trajectories of family dissatisfaction, the probability of living with a substance user, and drug treatment visits for women in SET and the Health Group.

Daniel J. Feaster, et al. Drug Alcohol Depend. ;111(3):227-234.
5.
Figure 4

Figure 4. From: A Randomized Controlled Trial of Structural Ecosystems Therapy for HIV Medication Adherence and Substance Abuse Relapse Prevention.

Mediation of SET's decrease in substance use days by engagement with treatment services. Note: only significant standardized pathways are shown; pathways from prior substance use to later substance use treatment were not statistically significant.

Daniel J. Feaster, et al. Drug Alcohol Depend. ;111(3):227-234.

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Write to the Help Desk